Sanara MedTech Stock Forecast for 2023 - 2025 - 2030

Updated on 04/25/2024

Stock Rating
11
Price Target
$44.00
Consensus
Outperform
Upside
35.38%
Analysts
0
Stock Rating
11
Upside
35.38%
Analysts
0
Price Target
$44.00

Sanara MedTech Stock Forecast and Price Target

The average price target for Sanara MedTech's stock of $44.00 recently provided by leading analysts would represent a 35.38% upside from its last closing price if reached. This potential increase is based on a high estimate of $44.00 and a low estimate of $44.00. If you want to buy SMTI stock, it might be a good idea to look at its competitors too.

$44.00

35.38% Upside

Buy
Buy

Sanara MedTech Fair Value Forecast for 2023 - 2025 - 2030

In the last zero years, Sanara MedTech's Price has seen an increase, rising from $0.00 to $0.00. This represents a growth of 100.00%. Analysts predict that Sanara MedTech's Fair Value will increase in the upcoming year, reaching $7.80. This would represent an increase of 100.00%. Over the next seven years, experts predict that Sanara MedTech's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$7.80
2025 Fair Value Forecast
$8.40
2026 Fair Value Forecast
$5.20
2027 Fair Value Forecast
$4.41
2028 Fair Value Forecast
$5.47
2029 Fair Value Forecast
$6.57
2030 Fair Value Forecast
$6.17

Sanara MedTech Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Sanara MedTech's Revenue has seen an increase, rising from $15.59M to $45.84M. This represents a growth of 194.03%. Analysts predict that Sanara MedTech's Revenue will increase in the upcoming year, reaching $85.60M. This would represent an increase of 86.74%. Over the next seven years, experts predict that Sanara MedTech's Revenue will grow at a rate of 18.47%.

2024 Rev Forecast
$0.09B
2025 Rev Forecast
$0.05B
2026 Rev Forecast
$0.05B
2027 Rev Forecast
$0.05B
2028 Rev Forecast
$0.06B
2029 Rev Forecast
$0.06B
2030 Rev Forecast
$0.05B

Sanara MedTech Dividend per Share Forecast for 2023 - 2025 - 2030

Sanara MedTech Free Cash Flow Forecast for 2023 - 2025 - 2030

Sanara MedTech EBITDA Forecast for 2023 - 2025 - 2030

Sanara MedTech's EBITDA has grown in the last two years, jumping from $-4.74M to $-9.86M – an increase of 108.02%. According to the 0 analysts polled, in the next year, Sanara MedTech's EBITDA will fall by 30.86%, reaching $-6.82M. By 2030, professionals believe that Sanara MedTech's EBITDA will have decreased by 25.58%, falling to $-7.34M.

2023 EBITDA Forecast
$-6817532.67
2024 EBITDA Forecast
$-6438023.35
2025 EBITDA Forecast
$-6851773.65
2026 EBITDA Forecast
$-7867663.29
2027 EBITDA Forecast
$-7525157.68
2028 EBITDA Forecast
$-7163950.11
2029 EBITDA Forecast
$-7084669.06
2030 EBITDA Forecast
$-7337591.75

Sanara MedTech EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Sanara MedTech's EBIT has increased by 143.14%, going from $-5.03M to $-12.23M. For the next year, 1 analysts project Sanara MedTech's EBIT to drop by 136.79%, reaching $4.50M. By 2030, professionals believe that Sanara MedTech's EBIT will decrease by 55.41%, reaching $-5.45M – a concerning trend for the company.

2024 EBIT Forecast
$0.00B
2025 EBIT Forecast
$0.01B
2026 EBIT Forecast
$-2024000.00
2027 EBIT Forecast
$-1789620.80
2028 EBIT Forecast
$-3878346.89
2029 EBIT Forecast
$-7837880.51
2030 EBIT Forecast
$-5453074.73

Sanara MedTech EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last zero years, Sanara MedTech's EPS has seen an increase, rising from $0.00 to $0.00. This represents a growth of 100.00%. Analysts predict that Sanara MedTech's EPS will increase in the upcoming year, reaching $0.52. This would represent an increase of 100.00%. Over the next seven years, experts predict that Sanara MedTech's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$0.52
2025 EPS Forecast
$0.56
2026 EPS Forecast
$0.35
2027 EPS Forecast
$0.29
2028 EPS Forecast
$0.36
2029 EPS Forecast
$0.44
2030 EPS Forecast
$0.41